JP2011528665A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011528665A5 JP2011528665A5 JP2011518930A JP2011518930A JP2011528665A5 JP 2011528665 A5 JP2011528665 A5 JP 2011528665A5 JP 2011518930 A JP2011518930 A JP 2011518930A JP 2011518930 A JP2011518930 A JP 2011518930A JP 2011528665 A5 JP2011528665 A5 JP 2011528665A5
- Authority
- JP
- Japan
- Prior art keywords
- denv
- polypeptide
- composition
- xaa
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8194308P | 2008-07-18 | 2008-07-18 | |
| US61/081,943 | 2008-07-18 | ||
| PCT/US2009/050966 WO2010009380A2 (en) | 2008-07-18 | 2009-07-17 | Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011528665A JP2011528665A (ja) | 2011-11-24 |
| JP2011528665A5 true JP2011528665A5 (https=) | 2012-09-13 |
| JP5806112B2 JP5806112B2 (ja) | 2015-11-10 |
Family
ID=41551029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011518930A Expired - Fee Related JP5806112B2 (ja) | 2008-07-18 | 2009-07-17 | デング出血熱およびデングショック症候群を含む免疫介在性デング熱感染症およびデング熱感染症の抗体依存性増強を処置するための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8815813B2 (https=) |
| EP (1) | EP2320924B1 (https=) |
| JP (1) | JP5806112B2 (https=) |
| CN (1) | CN102159231B (https=) |
| AU (2) | AU2009270805B2 (https=) |
| BR (1) | BRPI0915968B1 (https=) |
| CA (1) | CA2731218A1 (https=) |
| HR (1) | HRP20150620T1 (https=) |
| IL (1) | IL210717A (https=) |
| MX (1) | MX2011000647A (https=) |
| MY (1) | MY160699A (https=) |
| SG (1) | SG10201500597YA (https=) |
| WO (1) | WO2010009380A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2559887C (en) | 2004-03-10 | 2018-12-04 | Trinity Therapeutics, Inc. | Method for inhibiting immune complex formation in a subject |
| BRPI0915968B1 (pt) | 2008-07-18 | 2021-11-23 | Trinity Therapeutics, inc | Uso de polipeptídeo purificado para tratar infecção pelo vírus da dengue |
| WO2016106342A2 (en) * | 2014-12-22 | 2016-06-30 | Middle Tennessee State University | Methods for treating immune-mediated viral infections |
| US10227383B2 (en) * | 2015-05-20 | 2019-03-12 | Kagoshima University | Specific modification of antibody with IgG-binding peptide |
| WO2017189891A1 (en) * | 2016-04-27 | 2017-11-02 | Middle Tennessee State University | Methods for treating zika viral infections and associated complications |
| SG10202012408UA (en) | 2016-06-13 | 2021-01-28 | Univ Kagoshima | SITE-SPECIFIC RADIOISOTOPE-LABELED ANTIBODY USING IgG-BINDING PEPTIDE |
| CN115804362A (zh) * | 2023-02-08 | 2023-03-17 | 中国医学科学院医学生物学研究所 | 一种IFN-α/βR-/-小鼠抗体依赖性增强感染的注射液及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5189014A (en) * | 1979-12-03 | 1993-02-23 | Cowan Jr Fred M | Method of treating cellular Fc receptor mediated hypersensitivity immune disorders |
| US4383317A (en) * | 1980-10-30 | 1983-05-10 | Bei Electronics, Inc. | Shaft angle encoder having a circuit for synthesizing a skipped track output signal |
| IT1190891B (it) | 1982-06-24 | 1988-02-24 | Anic Spa | Metodo per la sintesi in fase solida di polipeptidi retroinvertiti |
| US5693758A (en) * | 1987-11-19 | 1997-12-02 | 501 Research Corporation Limited | Immunoglobulin E competitor |
| US5932483A (en) * | 1990-10-16 | 1999-08-03 | Northwestern University | Synthetic peptide and its uses |
| EP1400536A1 (en) * | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| US6420127B1 (en) * | 1994-11-18 | 2002-07-16 | Washington University | Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| WO1997033603A1 (en) * | 1996-03-13 | 1997-09-18 | Trustees Of The University Of Pennsylvania | Novel peptides which inhibit complement activation |
| ITMI962628A1 (it) | 1996-12-16 | 1998-06-16 | Tecnogen Scpa | Composizione farmaceutica |
| WO2000015214A1 (en) * | 1998-09-11 | 2000-03-23 | Ilexus Pty Limited | Fc RECEPTOR MODULATORS AND USES THEREOF |
| US20030190740A1 (en) | 1998-10-13 | 2003-10-09 | The University Of Georgia Research Foundation, Inc | Stabilized bioactive peptides and methods of identification, synthesis, and use |
| EP1121425B1 (en) * | 1998-10-13 | 2005-06-29 | The University Of Georgia Research Foundation, Inc. | Stabilized bioactive peptides and methods of identification, synthesis and use |
| EP2180054A1 (en) | 1999-12-24 | 2010-04-28 | Genentech, Inc. | Methods and compositions for prolonging elimination half-times of bioactive compounds |
| ATE368688T1 (de) | 2000-11-08 | 2007-08-15 | Fresenius Medical Care Affina | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen |
| US6916904B2 (en) * | 2002-04-24 | 2005-07-12 | Zolaris Biosciences, Llc | Inhibition of immune complex formation |
| US7351875B2 (en) | 2002-06-07 | 2008-04-01 | Trillium Therapeutics, Inc. | FcγRIIa transgenic animal model for autoimmune disease |
| AU2002953533A0 (en) | 2002-12-24 | 2003-01-16 | Arthron Limited | Fc receptor modulating compounds and compositions |
| CA2559887C (en) * | 2004-03-10 | 2018-12-04 | Trinity Therapeutics, Inc. | Method for inhibiting immune complex formation in a subject |
| KR101380200B1 (ko) | 2004-08-12 | 2014-04-01 | 헬신 세라퓨틱스 (유.에스.) 인크. | 성장 호르몬 분비촉진제를 이용하여 위장관계의 운동성을촉진하는 방법 |
| EP1940436B1 (en) * | 2005-09-06 | 2013-12-04 | Trinity Therapeutics, Inc. | Methods for treating immune mediated neurological diseases |
| WO2007068047A1 (en) | 2005-12-13 | 2007-06-21 | Trillium Therapeutics Inc | Multimeric fc receptor polypeptides |
| US20120021988A1 (en) * | 2007-08-14 | 2012-01-26 | Bodie Neil M | Methods for treating immune thrombocytopenia |
| BRPI0915968B1 (pt) | 2008-07-18 | 2021-11-23 | Trinity Therapeutics, inc | Uso de polipeptídeo purificado para tratar infecção pelo vírus da dengue |
-
2009
- 2009-07-17 BR BRPI0915968-1A patent/BRPI0915968B1/pt not_active IP Right Cessation
- 2009-07-17 MX MX2011000647A patent/MX2011000647A/es active IP Right Grant
- 2009-07-17 MY MYPI2011000225A patent/MY160699A/en unknown
- 2009-07-17 WO PCT/US2009/050966 patent/WO2010009380A2/en not_active Ceased
- 2009-07-17 CA CA2731218A patent/CA2731218A1/en not_active Abandoned
- 2009-07-17 SG SG10201500597YA patent/SG10201500597YA/en unknown
- 2009-07-17 US US13/054,738 patent/US8815813B2/en not_active Expired - Fee Related
- 2009-07-17 HR HRP20150620TT patent/HRP20150620T1/hr unknown
- 2009-07-17 CN CN200980136119.9A patent/CN102159231B/zh not_active Expired - Fee Related
- 2009-07-17 JP JP2011518930A patent/JP5806112B2/ja not_active Expired - Fee Related
- 2009-07-17 EP EP09798797.8A patent/EP2320924B1/en active Active
- 2009-07-17 AU AU2009270805A patent/AU2009270805B2/en not_active Ceased
-
2011
- 2011-01-18 IL IL210717A patent/IL210717A/en active IP Right Grant
-
2017
- 2017-02-03 AU AU2017200760A patent/AU2017200760A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011528665A5 (https=) | ||
| JP2010529860A5 (https=) | ||
| JP2020178703A5 (https=) | ||
| JP2006149395A5 (https=) | ||
| JP2020534828A5 (https=) | ||
| JP2006523711A5 (https=) | ||
| JP2015134758A5 (https=) | ||
| JP2007513634A5 (https=) | ||
| JP2014506790A5 (https=) | ||
| JP2015533490A5 (https=) | ||
| JP2011087580A5 (https=) | ||
| JP2009268467A5 (https=) | ||
| JP2014506450A5 (https=) | ||
| IL199263A (en) | Glucagon peptide with enhanced solubility, pharmaceutical composition containing it and its uses for drug preparation | |
| JP2019500414A5 (https=) | ||
| JP2003530124A5 (https=) | ||
| CN106232810A (zh) | 新的治疗 | |
| WO2005023992A3 (en) | Compositions and methods for inhibiting white spot syndrome virus (wssv) infection | |
| JP2005511038A5 (https=) | ||
| JP2006503088A5 (https=) | ||
| JP2008517998A5 (https=) | ||
| WO2009153518A3 (fr) | Nouvelles proteines de fusion et leur application pour la preparation de vaccins contre l'hepatite c | |
| JP2004532037A5 (https=) | ||
| WO2008142664A3 (en) | Exposed thymidine kinase 1 peptides, ligands and methods employing the same | |
| JP2007536910A5 (https=) |